Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
Instituto de Oftalmología Aplicada de Valladolid
Valladolid, EspañaInstituto de Oftalmología Aplicada de Valladolid-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2022
-
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study
BMJ open, Vol. 12, Núm. 3, pp. e051378
2021
-
Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21
2019
-
Transforming growth factor beta-induced p.(L558P) variant is associated with autosomal dominant lattice corneal dystrophy type IV in a large cohort of Spanish patients
Clinical and Experimental Ophthalmology, Vol. 47, Núm. 7, pp. 871-880
2018
-
Controlled Adverse Environment Chambers in Dry Eye Research
Current Eye Research, Vol. 43, Núm. 4, pp. 445-450
2015
-
Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma
Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4
2011
-
Activation of MAPK signaling pathway and NF-κB activation in pterygium and ipsilateral pterygium-free conjunctival specimens
Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 8, pp. 5842-5852
2009
-
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone
Experimental Eye Research, Vol. 89, Núm. 2, pp. 238-245
2006
-
Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: In vitro and in vivo studies
Journal of Biomedical Materials Research - Part A, Vol. 78, Núm. 2, pp. 343-351